Lumry WR - Search Results

1

The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression.

Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT. Lumry WR, et al. Allergy Asthma Proc. 2010 Sep-Oct;31(5):407-14. doi: 10.2500/aap.2010.31.3394. Allergy Asthma Proc. 2010. PMID: 20929608

2

EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema.

Levy RJ, Lumry WR, McNeil DL, Li HH, Campion M, Horn PT, Pullman WE. Levy RJ, et al. Among authors: lumry wr. Ann Allergy Asthma Immunol. 2010 Jun;104(6):523-9. doi: 10.1016/j.anai.2010.04.012. Ann Allergy Asthma Immunol. 2010. PMID: 20568386 Clinical Trial.

3

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.

Lumry WR, Li HH, Levy RJ, Potter PC, Farkas H, Moldovan D, Riedl M, Li H, Craig T, Bloom BJ, Reshef A. Lumry WR, et al. Ann Allergy Asthma Immunol. 2011 Dec;107(6):529-37. doi: 10.1016/j.anai.2011.08.015. Epub 2011 Oct 5. Ann Allergy Asthma Immunol. 2011. PMID: 22123383 Clinical Trial.

4

Hereditary angioedema: a case of near fatal laryngeal swelling in a 41-year-old woman.

Lumry WR. Lumry WR. Allergy Asthma Proc. 2011 Sep-Oct;32 Suppl 1:13-15. doi: 10.2500/aap.2011.32.3465. Allergy Asthma Proc. 2011. PMID: 22195756

5

Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.

Gower RG, Lumry WR, Davis-Lorton MA, Johnston DT, Busse PJ. Gower RG, et al. Among authors: lumry wr. Allergy Asthma Proc. 2012 May-Jun;33(3):235-40. doi: 10.2500/aap.2012.33.3573. Allergy Asthma Proc. 2012. PMID: 22584192 Review.

6

Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.

Grant JA, White MV, Li HH, Fitts D, Kalfus IN, Uknis ME, Lumry WR. Grant JA, et al. Among authors: lumry wr. Allergy Asthma Proc. 2012 Jul-Aug;33(4):348-53. doi: 10.2500/aap.2012.33.3585. Allergy Asthma Proc. 2012. PMID: 22856635 Clinical Trial.

7

Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study.

Lumry WR, Bernstein JA, Li HH, MacGinnitie AJ, Riedl M, Soteres DF, Craig TJ, Campion M, Iarrobino R, Stolz LE, Pullman WE. Lumry WR, et al. Allergy Asthma Proc. 2013 Mar-Apr;34(2):155-61. doi: 10.2500/aap.2013.34.3653. Allergy Asthma Proc. 2013. PMID: 23484891 Clinical Trial.

8

Overview of epidemiology, pathophysiology, and disease progression in hereditary angioedema.

Lumry WR. Lumry WR. Am J Manag Care. 2013 Jun;19(7 Suppl):s103-10. Am J Manag Care. 2013. PMID: 23844782 Free article.

9

Management and prevention of hereditary angioedema attacks.

Lumry WR. Lumry WR. Am J Manag Care. 2013 Jun;19(7 Suppl):s111-8. Am J Manag Care. 2013. PMID: 23844783 Free article.

10

US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency.

Zuraw BL, Banerji A, Bernstein JA, Busse PJ, Christiansen SC, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Riedl M; US Hereditary Angioedema Association Medical Advisory Board. Zuraw BL, et al. Among authors: lumry wr. J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):458-67. doi: 10.1016/j.jaip.2013.07.002. Epub 2013 Aug 30. J Allergy Clin Immunol Pract. 2013. PMID: 24565617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters